Global Rare Disease Genetic Testing Market By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders (CVDs), Dermatology Disease, Others), Technology (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping), Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests), End Use (Research Laboratories & CROs, Diagnostic Centers, Hospitals & Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Rare Disease Genetic Testing Market
Rare disease genetic testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 8.30% in the above-mentioned forecast period. The increase in the facilities for patients affected by rare diseases has been directly impacting the growth of rare disease genetic testing market.
Increasing need for an accurate and appropriate diagnosis for rare conditions is expected to have a significant impact on the rare disease genetic testing market. Other impactful reasons for the market growth are rise in the number of available registries, rising prevalence of rare disorders along with wide-ranging investments in the diagnosis of rare disorders. On the other hand, the growing number of patients undergoing disease testing and rising government assistance will further boost various new opportunities that will lead to the growth of the rare disease genetic testing market in the forecast period of 2020 to 2027.
Lack of regulatory framework in emerging economies associated with dearth of trained healthcare personnel is acting as major restraints to the growth of the rare disease genetic testing market in the above mentioned forecast period.
This rare disease genetic testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on rare disease genetic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Rare Disease Genetic Testing Market Scope and Market Size
Rare disease genetic testing market is segmented on the basis of disease type, technology, specialty and end use. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on disease type, the rare disease genetic testing market is segmented into neurological disorders, immunological disorders, hematology diseases, endocrine & metabolism diseases, cancer, musculoskeletal disorders, cardiovascular disorders (CVDs), dermatology disease and others.
- On the basis of technology, the rare disease genetic testing market is segmented into next-generation sequencing (NGS), array technology, PCR-based testing, fish, sanger sequencing, and karyotyping.
- Based on specialty, the rare disease genetic testing market is segmented into molecular genetic tests, chromosomal genetic tests and biochemical genetic tests.
- Rare disease genetic testing market has also been segmented based on the end use into research laboratories & CROS, diagnostic centers and hospitals & clinics.
Rare Disease Genetic Testing Market Country Level Analysis
Rare disease genetic testing market is analyzed and market size insights and trends are provided by country, disease type, technology, specialty and end use as referenced above.
The countries covered in the rare disease genetic testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the rare disease genetic testing market due to the large number of rare disorders registries and the presence of considerable numbers of R&D activities for rare & ultra-rare diseases, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the growing awareness and target population in the particular region.
The country section of the rare disease genetic testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Rare disease genetic testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for rare disease genetic testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the rare disease genetic testing market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Rare Disease Genetic Testing Market Share Analysis
Rare disease genetic testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to rare disease genetic testing market.
The major players covered in the rare disease genetic testing market report are Quest Diagnostics, Inc., Centogene N.V., Eurofins Scientific, Strand Life Sciences, Ambry Genetics, PerkinElmer, Inc., Macrogen, Inc., Baylor Genetics, Color, Health Network Laboratories, L.P., Preventiongenetics, Progenity, Inc., Invitae Corporation, 3billion, Inc., Arup Laboratories, Coopersurgical, Inc., Fulgent Genetics, Myriad Genetics, Inc., Laboratory Corporation Of America Holdings and Opko Health, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.